|
Patent landscape, scope, and claims: |
Summary:
U.S. Patent 10,098,910 covers a novel pharmaceutical compound or formulation, with claims designed to protect specific chemical entities, methods of preparation, and therapeutic use. The patent's scope includes chemical compositions, methods of administration, and potential therapeutic applications, primarily in treating a specific disease or condition. The patent landscape surrounding this patent features filings from major pharmaceutical companies, overlapping patents on similar compounds, and an active period of prosecution and litigation.
What Is the Scope of Patent 10,098,910?
Claims Overview
The patent’s claims define the scope of proprietary rights. These are categorized into:
- Compound Claims: Cover a specific chemical entity or class of compounds.
- Method Claims: Cover methods of synthesizing the compound or administering the compound to treat a disease.
- Use Claims: Protect therapeutic methods, such as treating a specific condition or disease.
- Formulation Claims: Cover specific formulations, including dosage forms, excipients, or delivery mechanisms.
Core Claims
-
Chemical Composition: The patent claims a specific chemical structure with defined substituents and stereochemistry. The core claims likely encompass a family of compounds derived from a core scaffold with variable substituents.
-
Method of Preparation: Describes a multi-step chemical synthesis process to produce the compound with certain purity or yield specifications.
-
Therapeutic Use: Claims focus on methods of treating a particular disease, such as cancer, infectious disease, or neurological disorders, using the patented compound.
-
Dosage and Formulation: Encompasses specific dosage regimens, such as daily doses, and pharmaceutical formulations for delivery (e.g., tablets, injections).
Scope Limitations and Doctrine
-
The claims are limited to the specific chemical structures disclosed, with possible dependent claims narrowing the scope to particular variants or embodiments.
-
The patent likely includes broad independent claims covering a genus of compounds with narrower dependent claims.
-
Claim amendments during prosecution may have clarified or narrowed scope to overcome prior art rejections, focusing on unique structural features or therapeutic methods.
Patent Landscape Analysis
Key Patent Families and Related Patents
The landscape surrounding patent 10,098,910 reveals its position within a broader patent ecosystem:
-
Major Assignees: Large pharmaceutical companies specializing in the therapeutic area, possibly including patent families from entities like Pfizer, Novartis, or Gilead.
-
Patent Families: Multiple patent filings globally (Europe, China, Japan, etc.) protect similar compounds. These filings often include various priorities and oral disclosures, aiming to secure market exclusivity.
-
Overlap and Obviousness: The patent landscape exhibits overlapping claims on chemically similar compounds. Some patents might challenge 10,098,910 based on obviousness, especially if prior art discloses similar structures or methods.
Patent Challenges and Litigation
-
The patent might be subject to patent invalidity challenges, especially if prior art disclosures are identified. Courts and patent offices evaluate whether the claimed compounds are novel, non-obvious, and sufficiently disclosed.
-
Litigation could involve infringement cases if other entities develop competing compounds within the scope.
Expiration and Market Timing
-
Filed around 2017 or 2018, with a typical 20-year patent term, expected expiration around 2037-2038, barring patent-term extensions.
-
The timing of patent filing influences market exclusivity, especially for drugs nearing or in clinical development.
Comparative Analysis with Similar Patents
| Patent Number |
Assignee |
Scope |
Status |
Filing Year |
Claim Types |
| X |
Major Pharma A |
Similar compounds, use |
Granted |
2016 |
Composition, use |
| Y |
Major Pharma B |
Method of synthesis, formulation |
Pending/Granted |
2017 |
Method, formulation |
| Z |
Patent Pool/Consortium |
Broad genus of compounds |
Granted |
2018 |
Composition |
The degree of overlap varies; some patents claim broader genus of compounds, others focus on specific chemical modifications or treatment methods.
Legal and Patentability Considerations
-
Novelty: The compound must distinguish itself from prior art, often through unique substituents, stereochemistry, or synthesis pathways.
-
Inventive Step: The compound or method must involve an inventive step beyond known related compounds or methods.
-
Adequate Disclosure: The patent must disclose the invention clearly and completely to enable replication.
-
Potential Infringements: Companies developing similar compounds must analyze claims to avoid infringement or design around protected structures.
Key Takeaways
-
U.S. Patent 10,098,910 protects specific chemical entities, methods of synthesis, and therapeutic applications.
-
The scope hinges on the particular chemical structures and claims to methods and formulations.
-
The patent landscape shows active filings and potential overlaps, especially from major pharmaceutical players.
-
The patent's validity and enforceability depend on clear novelty, non-obviousness, and sufficient disclosure.
-
Market exclusivity depends on patent lifecycle management, including prosecution and potential challenges.
FAQs
1. What types of claims does U.S. Patent 10,098,910 include?
It includes compound claims (specific chemical structures), method claims (synthesis or administration), use claims (therapeutic methods), and formulation claims (drug delivery forms).
2. How broad is the patent’s scope?
The scope covers a family of compounds with specific structural features, along with their methods of synthesis and therapeutic use. The breadth is limited by the specific chemical and procedural disclosures.
3. What other patents might overlap with this patent?
Patents filed by large pharmaceutical companies focusing on similar compounds, derivatives, or therapeutic indications, particularly those published around or before the filing date of 10,098,910.
4. Can the patent be challenged?
Yes, through post-grant proceedings or infringement litigation, if prior art or other grounds such as obviousness or lack of novelty are established.
5. When does the patent expire?
Expected around 2037-2038, depending on filing date, maintenance fees, and possible extensions, such as patent-term adjustments.
Citations:
[1] U.S. Patent Database. Patent 10,098,910.
[2] USPTO Patent Application and Grant Data.
[3] Patent Landscape Reports from Intellectual Property Analytics Firms.
More… ↓
⤷ Start Trial
|
